H. Akköprü Et Al. , "Peripheral Expression of ADORA2A Is Increased and Is Correlated with Autism Spectrum Disorder Severity in a Sample of Turkish Children," Psychiatry and Clinical Psychopharmacology , vol.33, no.1, pp.14-19, 2023
Akköprü, H. Et Al. 2023. Peripheral Expression of ADORA2A Is Increased and Is Correlated with Autism Spectrum Disorder Severity in a Sample of Turkish Children. Psychiatry and Clinical Psychopharmacology , vol.33, no.1 , 14-19.
Akköprü, H., Alnak, A., Karadoğan, Z. N., ÇAĞLAYAN, A. O., Özçetin, M., & Coşkun, M., (2023). Peripheral Expression of ADORA2A Is Increased and Is Correlated with Autism Spectrum Disorder Severity in a Sample of Turkish Children. Psychiatry and Clinical Psychopharmacology , vol.33, no.1, 14-19.
Akköprü, Hilal Et Al. "Peripheral Expression of ADORA2A Is Increased and Is Correlated with Autism Spectrum Disorder Severity in a Sample of Turkish Children," Psychiatry and Clinical Psychopharmacology , vol.33, no.1, 14-19, 2023
Akköprü, Hilal Et Al. "Peripheral Expression of ADORA2A Is Increased and Is Correlated with Autism Spectrum Disorder Severity in a Sample of Turkish Children." Psychiatry and Clinical Psychopharmacology , vol.33, no.1, pp.14-19, 2023
Akköprü, H. Et Al. (2023) . "Peripheral Expression of ADORA2A Is Increased and Is Correlated with Autism Spectrum Disorder Severity in a Sample of Turkish Children." Psychiatry and Clinical Psychopharmacology , vol.33, no.1, pp.14-19.
@article{article, author={Hilal Akköprü Et Al. }, title={Peripheral Expression of ADORA2A Is Increased and Is Correlated with Autism Spectrum Disorder Severity in a Sample of Turkish Children}, journal={Psychiatry and Clinical Psychopharmacology}, year=2023, pages={14-19} }